Life Insurance with Hashimoto’s Disease in Canada

By Parvesh Benning, Licensed Life Insurance Broker

Once your thyroid is controlled, the autoimmune part of Hashimoto’s matters far less to an underwriter than it does to you.

Most Canadians with well-controlled Hashimoto’s can qualify for standard life insurance rates, and many are surprised by that. What an underwriter actually weighs is not the diagnosis but the stability behind it: steady thyroid levels, a medication dose that has not changed recently, and no open investigations. This guide covers how that assessment works, how Canadian insurers differ, and what to do if one of them rates or postpones you.

Updated: June 2, 2026

Life insurance planning for Hashimoto’s disease with thyroid health symbolism

Life Insurance with Hashimoto’s Disease in Canada

By Parvesh Benning, Licensed Life Insurance Broker, Updated: June 2, 2026

Get my quick quoteCompare Canadian insurers in about 1 minute. No obligation.

Most Canadians with well-controlled Hashimoto’s can qualify for standard life insurance rates, and many are surprised by that. What an underwriter actually weighs is not the diagnosis but the stability behind it: steady thyroid levels, a medication dose that has not changed recently, and no open investigations. This guide covers how that assessment works, how Canadian insurers differ, and what to do if one of them rates or postpones you.

Life insurance planning for Hashimoto’s disease with thyroid health symbolism

The real question is rarely whether you can get covered with Hashimoto’s. For most people whose thyroid is in a steady state, you can. The question worth asking is which insurer to apply to first, and whether now is the right time to apply at all.

That is where a diagnosis like Hashimoto’s gets misread. Clients fixate on the autoimmune label and their antibody numbers. Underwriters look somewhere else entirely: at how long your thyroid levels have held, whether your medication dose has changed recently, and whether anything is still being investigated. Get those three things lined up and the diagnosis itself barely moves the needle.

Can you get life insurance with Hashimoto’s disease in Canada? Usually yes, often at standard rates.

When your thyroid is controlled and your treatment has been steady, most Canadian insurers underwrite Hashimoto’s as a routine case. A recent diagnosis or a recent change in dose can mean a short wait or a temporary rating, but that is not a dead end. There is often a path to some form of coverage today.

Controlled and stable

Often standard rates on a fully underwritten policy, the same as treated hypothyroidism without the autoimmune part.

What underwriters weigh

Stability, recency of any dose change, and whether investigations are still open. Not the diagnosis label on its own.

Newly diagnosed or dose changed

A no-medical or simplified policy can cover you now, while you build the track record for a better rate later.

How Hashimoto’s affects a life insurance application

Once Hashimoto’s is treated and your thyroid is controlled, it is usually underwritten the same way as ordinary treated hypothyroidism. That is the part most people miss. The autoimmune label sounds a lot scarier to clients than it does to an underwriter.

Hashimoto’s is an autoimmune condition. Your immune system goes after the thyroid gland, and over time that usually leads to an underactive thyroid. So you take levothyroxine, your levels come back into range, and you carry on. From a mortality standpoint, a controlled thyroid is a controlled thyroid. Whether the underlying cause was Hashimoto’s or something else does not change much once the numbers are steady.

Where clients get tangled up is the antibody piece. They see high TPO antibodies on a lab report and assume that flags them as a worse risk. It rarely works that way. Antibodies confirm the diagnosis. They do not tell an insurer your thyroid is out of control. The thing being priced is stability, not the immune mechanism behind it.

What clients worry about

“It’s autoimmune, my body is attacking itself, my antibodies are high, so I’ll get rated or declined.”

What an underwriter sees

A treated thyroid with steady levels and a stable dose. Routine. Often standard rates, same as plain hypothyroidism.

None of this means Hashimoto’s is invisible on an application. You disclose it, you provide the details, and the insurer reviews it. It just means the diagnosis on its own is not the thing that decides your outcome. If you want the broader picture across autoimmune conditions, our guide on life insurance with an autoimmune disease covers how the same logic applies to conditions like lupus and rheumatoid arthritis.

What underwriters actually check

Underwriters look at three things: how stable your thyroid levels have been, whether your medication dose has changed recently, and whether anything is still being investigated. The diagnosis label itself drives almost none of the decision. The activity around it does.

Here is the order I think about it in when a Hashimoto’s file comes across my desk.

1

Stability. Have your thyroid levels held steady? Insurers like to see normal results that have stayed normal. A number trending back into range is a positive signal, not a negative one. They are reading the trend, not hunting for one bad lab.

2

Recency of any change. Has your dose moved in the last 6 to 12 months? A recent adjustment is the single thing most likely to slow an application down, because the insurer wants to see the new dose settle. It is not a decline. It is a “let’s wait” signal.

3

Open investigations. Anything your doctor is still chasing, a nodule being watched, an ultrasound pending, a referral not yet closed, will get an application deferred. Whether you apply fully underwritten or no-medical, an open investigation pauses things. Best to close those out first.

On a fully underwritten policy you complete the application and questionnaire, and the insurer may ask for a report from your doctor confirming your history and recent levels. That report is just the paper trail that backs up your stability. Provide it and most well-controlled files move through cleanly.

One thing worth knowing about the no-medical route: many of those applications do not even ask about thyroid specifically. They ask broader questions, like whether you have any ongoing investigations, recent abnormal results, or medication that has not been stable. If your thyroid has been quiet for a while, you often sail past those questions without the diagnosis ever becoming the issue. If a recent medication change is the snag, our guide on medications that can affect a life insurance application explains how timing works.

How Canadian insurers compare

Most major Canadian insurers can approve well-controlled Hashimoto’s at standard rates, but they do not all read a file the same way, and that is exactly why which insurer you apply to first matters. The same person can come back standard at one carrier and rated at another, on identical health.

I am not going to pretend every company publishes a Hashimoto’s rule. They do not. What they publish is how they treat controlled thyroid conditions, and that is what I route on. Here is the posture I work with on the fully underwritten side.

Insurer Controlled, stable thyroid (possible outcome) What can change it
Manulife Standard may be possible if controlled on medication Recent dose change or other health factors
Empire Life Treated with no symptoms: Standard may be possible Treated with symptoms or complications: a rating up to decline depending on the picture
Foresters Standard may be possible for controlled thyroid Unresolved nodules or thyroid cancer assessed separately
Canada Life and Sun Life May consider controlled thyroid for standard, subject to the full file Recency, other conditions, overall profile

Outcomes are illustrative only and depend on the full application. Always work through the application with a licensed broker before assuming eligibility or rate class.

What I do with this in practice is simple. Before anyone submits anything official, I match the file to the carrier most likely to read it favourably. A controlled Hashimoto’s case with steady levels is a strong fit for the fully underwritten majors above. A recently adjusted dose, or a profile with other health factors stacked on top, may route better through a simplified or no-medical carrier instead, where companies like Industrial Alliance, Canada Protection Plan, and Assumption Life can cover you without the same medical scrutiny.

This is the part you cannot do on your own, going direct to one company. Apply to one insurer, get a rating, and that is your answer, when a different carrier might have come back standard for the exact same history. A broker compares those postures across companies before you submit a formal application, in roughly the same time it takes you to fill out a single one.

What it costs and what moves your rate

For most people with well-controlled Hashimoto’s, the thyroid itself does not change the price. You pay close to what anyone your age and health would pay, because once it is stable it is priced like ordinary treated hypothyroidism. What moves your rate is everything around the thyroid, not the diagnosis.

I am not going to throw fake premium numbers at you. Anyone quoting you an exact monthly price for “Hashimoto’s” off a web page is guessing, because the price tracks your whole profile, not the label. Here is what actually shifts it.

  • How long it has been stable. Years of steady levels read better than a diagnosis from last month. Time is on your side here.
  • Whether the dose is settled. A medication change inside the last 6 to 12 months is the most common reason a price comes back higher than expected, or an application waits.
  • Smoking status. This swings a premium far harder than a controlled thyroid does. If tobacco, vaping, or cannabis is part of the picture, see our guide on life insurance for smokers in Canada.
  • Other health factors. Blood pressure, weight, diabetes, or a second autoimmune condition layered on top will weigh more than the Hashimoto’s on its own.
  • Age and coverage amount. The usual levers. Younger and lower face amounts price cheaper, same as for anyone.

The takeaway: if your thyroid is the only thing on your file and it is controlled, do not expect a thyroid surcharge. Expect a normal rate. The honest way to find your actual number is a quote run against several carriers at once, not a guess pulled from an article.

Want your real number instead of a guess?

We compare controlled-Hashimoto’s pricing across Canadian carriers and tell you which one reads your file best, before you ever submit an application.

Get a quote

Types of coverage available

You have access to the same policies as anyone else: term, permanent, and no-medical. Hashimoto’s does not lock you out of any of them. It only influences which one is the smarter starting point, depending on how settled your thyroid is.

Quick read on where each one fits a Hashimoto’s file:

Term life

The usual fit. Affordable, covers a set window like 20 or 30 years, and most controlled cases land at or near standard rates. This is where I start for the majority of stable Hashimoto’s clients.

Permanent and whole life

Lifelong coverage that builds cash value. Costs more than term, but stable applicants qualify the same way. Worth it when the goal is estate planning or coverage that never expires.

No-medical and simplified

Fewer health questions, faster issue. Useful if you were recently diagnosed, just changed dose, or want to skip the medical. Lower amounts and higher premiums, but coverage in place now.

For most stable applicants, term is the cost-effective answer and the thyroid never becomes a sticking point. The no-medical route earns its place when timing is the problem rather than the diagnosis. If you want the full breakdown of how those work, see our guide on no-medical life insurance.

If you are newly diagnosed or recently changed dose

If you were just diagnosed, or your levothyroxine dose changed in the last few months, the smart move is usually to wait a little, or to apply no-medical now and upgrade later. A recent change is the one thing most likely to slow a fully underwritten file down, because the insurer wants to watch the new dose settle.

That is not a decline. It is a timing issue. And timing is fixable.

Dose just changed? Once it has been steady for 6 to 12 months, a fully underwritten application reads much cleaner. If you need coverage in the meantime, a no-medical policy can bridge the gap and you re-shop once stable.

Investigation still open? A nodule being watched or a pending ultrasound will defer any application. Close it out first, then apply. Trying to push through an open file just wastes a decision.

Genuinely stable already? Then there is nothing to wait for. Apply fully underwritten and aim for standard.

When you do apply, having a few things ready speeds it up: your diagnosis date, your current dose, your recent thyroid lab values with dates, and any specialist notes. That is the paper trail that shows stability, and it is most of what an underwriter wants to see. Get those in front of the right carrier and a controlled file can often move more smoothly.

What to do if you are rated or postponed

A rating or postponement from one insurer is not a decline everywhere. A postponed decision in one place does not mean it is postponed in every place. That single fact is where I save Hashimoto’s clients the most money.

The companies do not share one rulebook. One carrier asks about thyroid history in the last two years, another three, another five. Same with how they treat a recent dose change or a watched nodule. So a file that gets a rating, or a “come back in a year,” at company A can be a clean approval at company B, on identical health.

What I see in practice

I have seen a rating come back so steep the policy was barely worth buying, then placed the same person with a simplified carrier for less money and immediate coverage. Not because simplified was objectively better, but because that one rating pushed them into an expensive corner a different route avoided entirely.

A decline or a rating is a starting point for re-routing. Not a stop sign.

So when someone comes to me already rated or postponed, the process is the same every time. Four steps, in order:

STEP 1

Find out what actually triggered it. Usually recency, a recent dose change, or an open investigation. Rarely the Hashimoto’s itself.

STEP 2

If it is timing, decide: wait for stability, or bridge with no-medical coverage now and re-shop later.

STEP 3

If it is carrier fit, move the file to a company whose questions and posture suit your history better.

STEP 4

Compare a rated fully underwritten policy against a clean simplified one. Sometimes simplified wins on price. Sometimes it does not. You only know by comparing.

That is the whole argument for not going direct to a single insurer. One company gives you one answer. A broker who knows where each carrier draws its lines turns one rating into a comparison, and a comparison almost always finds a better landing spot. If a postponement is where you are right now, our guide on guaranteed and simplified issue life insurance walks through the coverage that stays open to you in the meantime.

Frequently asked questions

Q1

Can I get life insurance with Hashimoto’s disease in Canada?

Yes. Most people with well-controlled Hashimoto’s qualify for life insurance, often at standard rates. Insurers focus on whether your thyroid levels are stable and your medication dose has been steady, not on the diagnosis itself.

Q2

Will Hashimoto’s raise my premiums?

Usually not, if it is controlled. A stable thyroid is priced like ordinary treated hypothyroidism. A recent diagnosis, a recent dose change, or other health conditions are what tend to move the rate, not the autoimmune label on its own.

Q3

Do high TPO antibodies hurt my application?

Rarely. Antibodies confirm the diagnosis, but they do not tell an underwriter your thyroid is out of control. What gets priced is stability: steady levels and a settled dose. The antibody number on its own is not the deciding factor.

Q4

I was just diagnosed. Should I wait to apply?

Often it helps to let the dose settle for 6 to 12 months before applying fully underwritten. If you need coverage sooner, a no-medical policy can cover you now and you can re-shop for a better rate once your record shows stability.

Q5

Is Hashimoto’s the same as hypothyroidism for insurance?

Once treated and controlled, yes, it is usually underwritten the same way. Hashimoto’s is a common cause of an underactive thyroid, and once levels are steady the insurer treats it like any controlled hypothyroid case. Our guide to life insurance with hyperthyroidism and hypothyroidism covers the broader thyroid picture.

Q6

One insurer rated me. Are my options gone?

No. A rating or postponement at one company does not mean every company will decide the same way. Carriers draw their lines differently, so a file that gets rated at one can be approved at another on identical health. This is exactly where comparing carriers pays off.

Q7

Does Hashimoto’s count as a disability for life insurance?

That is a separate question from life insurance, which is about coverage and rates, not disability status. If income protection is your concern, that is handled through disability coverage instead. See our overview of group versus individual disability insurance.

Hashimoto’s alone should not decide your rate. Carrier fit matters.

If your thyroid is controlled and there are no major related health concerns, standard rates may be possible. The real question is which insurer reads your file best, and that is the one thing you cannot answer by applying to a single company on your own.

We compare Canadian carriers against your exact history, help identify the route most likely to fit, and handle the paperwork so a stable file is presented clearly. No cost to you to find out where you land.

Talk to a broker directly

1-877-654-6119

Get a free quote
Get in touch

Based in Hamilton and serving clients across Ontario, British Columbia, Alberta, Manitoba, Saskatchewan, Nova Scotia, and New Brunswick, including Waterloo, Kingston, Calgary, and Nanaimo.